Tonix Pharmaceuticals approved to list on Nasdaq Global Select Market

Tonix Pharmaceuticals (TNXP) announced that it has received approval from Nasdaq to transfer the listing of its common stock from the Nasdaq Capital Market to the Nasdaq Global Select Market. Trading on the Nasdaq Global Select Market is expected to commence at the open of market on March 3 under the company’s existing ticker symbol “TNXP.”